Загрузка...
Response to Immunotherapy in Combination With Mitotane in Patients With Metastatic Adrenocortical Cancer
Adrenocortical carcinoma (ACC) is a rare orphan disease with a dismal prognosis. Surgery remains the first-line treatment, but most patients eventually develop metastatic disease. Mitotane is often used with chemotherapy with modest success. Little information is available concerning the efficacy of...
Сохранить в:
| Опубликовано в: : | J Endocr Soc |
|---|---|
| Главные авторы: | , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Endocrine Society
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6853671/ https://ncbi.nlm.nih.gov/pubmed/31745526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-00305 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|